Macquarie Sticks to Its Hold Rating for Australian Clinical Labs Ltd (ACL)
ACL: Strong FY26 margin and cash flow, with stable outlook and continued shareholder returns
Australian Clinical Labs Sets Date and Nomination Deadline for 2026 AGM
ASX Penny Stock Highlights: Australian Clinical Labs Among 3 Noteworthy Picks
United Super exits substantial holder position in Australian Clinical Labs
Australian Clinical Labs Updates Market on Progress of On-Market Share Buy-Back